[HTML][HTML] Effect of valsartan on the incidence of diabetes and cardiovascular events

NAVIGATOR Study Group - New England Journal of Medicine, 2010 - Mass Medical Soc
Background It is not known whether drugs that block the renin–angiotensin system reduce
the risk of diabetes and cardiovascular events in patients with impaired glucose tolerance …

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005) The Task Force for the Diagnosis and Treatment of Chronic …

K Swedberg, J Cleland, H Dargie… - European heart …, 2005 - academic.oup.com
Guidelines and Expert Consensus Documents produced by Task Forces, expert groups, or
consensus panels. The chosen experts in these writing panels are asked to provide …

Neprilysin inhibitors in heart failure: the science, mechanism of action, clinical studies, and unanswered questions

B Bozkurt, AP Nair, A Misra, CZ Scott, JH Mahar… - Basic to Translational …, 2023 - jacc.org
This article provides a contemporary review and a new perspective on the role of neprilysin
inhibition in heart failure (HF) in the context of recent clinical trials and addresses potential …

Sex and gender differences in myocarditis and dilated cardiomyopathy

DL Fairweather, LT Cooper Jr, LA Blauwet - Current problems in cardiology, 2013 - Elsevier
Heart failure due to nonischemic dilated cardiomyopathy (DCM) contributes significantly to
the global burden of cardiovascular disease. Myocarditis is, in turn, a major cause of acute …

Systolic heart failure

JJV McMurray - New England Journal of Medicine, 2010 - Mass Medical Soc
A 74-year-old man with a history of hypertension and myocardial infarction that had occurred
in the remote past presents with breathlessness on exertion. On examination, his pulse is 76 …

Association between antihypertensive treatment and adverse events: systematic review and meta-analysis

A Albasri, M Hattle, C Koshiaris, A Dunnigan, B Paxton… - bmj, 2021 - bmj.com
Objective To examine the association between antihypertensive treatment and specific
adverse events. Design Systematic review and meta-analysis. Eligibility criteria Randomised …

Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced …

DG Kramer, TA Trikalinos, DM Kent… - Journal of the American …, 2010 - jacc.org
Objectives: The purpose of this study was to quantitatively assess the relationship between
therapy-induced changes in left ventricular (LV) remodeling and longer-term outcomes in …

Mechanisms and models in heart failure: the biomechanical model and beyond

DL Mann, MR Bristow - Circulation, 2005 - Am Heart Assoc
resultant striking increase in morbidity and mortality. The transition to symptomatic heart
failure is accompanied by further activation of neurohormonal and cytokine systems, as well …

High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE …

JT Heywood, GC Fonarow, MR Costanzo… - Journal of cardiac …, 2007 - Elsevier
BACKGROUND: The prevalence of renal dysfunction in patients hospitalized with acute
decompensated heart failure remains poorly characterized. METHODS AND RESULTS …

Essential hypertension

JA Staessen, J Wang, G Bianchi, WH Birkenhäger - The Lancet, 2003 - thelancet.com
Hypertension is a frequent, chronic, age-related disorder, which often entails debilitating
cardiovascular and renal complications. Blood pressure is usually noted in combination with …